---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-002610"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2025-02-03T23:59:59+00:00"
generated_at: "2026-05-27T04:01:13.667981+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# NRx Pharma secures $27M financing for subsidiary Hope Therapeutics clinic rollup

## Summary
- Private placement of 732,600 shares at $2.73/share for $2M immediate funding.
- Investor committed to $25M in Hope Series A Preferred convertible into 1/3 equity, 15% dividend, non-callable for 2 years.
- First $6.75M tranche of Hope investment due by Feb 7, 2025; remaining $18.25M by Apr 1, 2025.
- Funds to acquire Kadima Neuropsychiatry and start nationwide interventional psychiatry clinic rollup.
- Company anticipates pro-forma revenue of ~$100M by end of 2025 using bank leverage.

## SEC filing metadata
- accession: 0001437749-25-002610
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2025-02-03T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000143774925002610/0001437749-25-002610-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000143774925002610/nrxp20250203_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-002610
- JSON: https://secwatch.observer/filing/0001437749-25-002610.json
- Plain text: https://secwatch.observer/filing/0001437749-25-002610.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.